CD8A and COVID-19: In addition to a significant reduction in both CD4+ and CD8+ T lymphocyte subsets in COVID‐19 patients, severe cases had much lower CD8+ lymphocytes and a subsequent increase positively correlated with improved clinical outcomes.18